Maxim Group Initiates Coverage On Health In Tech with Buy Rating, Announces Price Target of $2.5
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Maxim Group analyst Allen Klee initiates coverage on Health In Tech (NASDAQ:HIT) with a Buy rating and announces Price Target of $2.5.
Maxim Group analyst Allen Klee initiates coverage on Health In Tech (NASDAQ:HIT) with a Buy rating and announces Price Target of $2.5.